OVAX Trademark

Trademark Overview


On Friday, October 13, 2023, a trademark application was filed for OVAX with the United States Patent and Trademark Office. The USPTO has given the OVAX trademark a serial number of 98223304. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 8, 2024. This trademark is owned by OVAX Inc.. The OVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical development
ovax

General Information


Serial Number98223304
Word MarkOVAX
Filing DateFriday, October 13, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized word "OVAX" in navy blue, except for the bottom tips of the letter "A", which are red and separated from the upper navy blue portion of the "A".
Indication of Colors claimedThe colors red and navy blue are claimed as a feature of the mark.
Goods and ServicesPharmaceutical development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 17, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOVAX Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77027

Party NameOVAX Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77027

Trademark Events


Event DateEvent Description
Tuesday, October 17, 2023NEW APPLICATION ENTERED
Tuesday, October 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 18, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 31, 2024NON-FINAL ACTION WRITTEN
Friday, June 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, June 29, 2024FINAL REFUSAL WRITTEN
Saturday, June 29, 2024FINAL REFUSAL E-MAILED
Wednesday, July 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2024NON-FINAL ACTION E-MAILED
Friday, May 31, 2024ASSIGNED TO EXAMINER
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords


ovax development pharmaceutical